drugset / Trial / NCT00648986

Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails

NCT00648986

Phase 4 Completed 20 enrolled Columbia University Allergan · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether topical tazarotene (Tazorac), a receptor-selective synthetic retinoid that normalizes epidermal differentiation, ameliorates signs and symptoms of brittle nails.

Timeline

Start
2005-08
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tazarotene Small molecule Topical

Indications

No indication recorded.